MK

Meenakshi Kumawat

Active Director Director DIN 11733822
DIN 11733822 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Meenakshi Kumawat

Data last updated:

Meenakshi Kumawat is a Director at Medbyte Technologies Private Limited (since 2026).

DIN 11733822
Primary Designation Director
First Appointment 21 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medbyte Technologies Private Limited U63119UW2026PTC253543
Director21 May 20262026Active

Board colleagues of Meenakshi Kumawat

NameDINCompanyDesignation
Monika Kumawat11733823Medbyte Technologies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medbyte Technologies Private Limited
Premium access

Shareholding and investment profile for Meenakshi Kumawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenakshi Kumawat

Meenakshi Kumawat currently holds 1 directorship: Medbyte Technologies Private Limited (Director, since 21 May 2026).

Meenakshi Kumawat was first appointed on 21 May 2026 as Director at Medbyte Technologies Private Limited.

The current boards of Meenakshi Kumawat's companies include Monika Kumawat (Medbyte Technologies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available